These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 17357129

  • 1. Sweating in Parkinsonian patients with wearing-off.
    Pursiainen V, Haapaniemi TH, Korpelainen JT, Sotaniemi KA, Myllylä VV.
    Mov Disord; 2007 Apr 30; 22(6):828-32. PubMed ID: 17357129
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pharmacokinetic and pharmacodynamic comparison of ropinirole 24-hour prolonged release and ropinirole immediate release in patients with Parkinson's disease.
    Tompson D, Oliver-Willwong R.
    Clin Neuropharmacol; 2009 Apr 30; 32(3):140-8. PubMed ID: 18978485
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Helicobacter pylori infection and motor fluctuations in patients with Parkinson's disease.
    Lee WY, Yoon WT, Shin HY, Jeon SH, Rhee PL.
    Mov Disord; 2008 Sep 15; 23(12):1696-700. PubMed ID: 18649391
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pain intensity on and off levodopa in patients with Parkinson's disease.
    Nebe A, Ebersbach G.
    Mov Disord; 2009 Jun 15; 24(8):1233-7. PubMed ID: 19412949
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Study of associated clinical variables and phenomenology of hallucinations in Parkinson's].
    Cubo E, González M, Aguilar A, Quintana S.
    Neurologia; 2006 Jun 15; 21(1):12-8. PubMed ID: 16525921
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Sudomotor dysfunction in Parkinson's disease].
    Yoshioka M, Oka H, Morita M, Inoue K.
    Rinsho Shinkeigaku; 2003 Jul 15; 43(7):379-84. PubMed ID: 14582362
    [Abstract] [Full Text] [Related]

  • 14. Effects of ropinirole on nonmotor symptoms of Parkinson disease: a prospective multicenter study.
    Rektorova I, Balaz M, Svatova J, Zarubova K, Honig I, Dostal V, Sedlackova S, Nestrasil I, Mastik J, Bares M, Veliskova J, Dusek L.
    Clin Neuropharmacol; 2008 Jul 15; 31(5):261-6. PubMed ID: 18836343
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The effect of pramipexole on mood and motivational symptoms in Parkinson's disease: a meta-analysis of placebo-controlled studies.
    Leentjens AF, Koester J, Fruh B, Shephard DT, Barone P, Houben JJ.
    Clin Ther; 2009 Jan 15; 31(1):89-98. PubMed ID: 19243709
    [Abstract] [Full Text] [Related]

  • 19. End-of-dose wearing off in Parkinson disease: a 9-question survey assessment.
    Stacy M, Hauser R, Oertel W, Schapira A, Sethi K, Stocchi F, Tolosa E.
    Clin Neuropharmacol; 2006 Jan 15; 29(6):312-21. PubMed ID: 17095894
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.